Search Results 1041-1050 of 17037 for monoclonal antibody
Description. Immune globulin-hipp injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...
... antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. Participation eligibility. Participant eligibility ...
Monoclonal antibodies ≤ 2 weeks;; Note: denosumab is exempt from this requirement and can be started at any time prior to initiation of palbociclib and ...
... monoclonal antibody (mAb) targeting MET (such as onartuzumab [MetMAb]); The subject has received radionuclide treatment =< 6 weeks of the first dose of study ...
... antibody levels. The researchers found that transplanting the liver first decreases a patient's donor-specific alloantibody (DSA) levels, helping to avoid ...
... antibody therapy within 42 days of registration; patients may have ... Monoclonal antibodies must not have been received for 1 week prior to registration; ...
Prior anti-cancer monoclonal antibody (mAb) therapy for direct anti-neoplastic treatment within 4 weeks prior to study Day 1; Prior chemotherapy, targeted ...
Children who developed Hib disease when 24 months of age or older do not need to be immunized, since most children in this age group will develop antibodies ...
Prior use of lenalidomide, or monoclonal antibodies against CTLA-4, PD-1, or PD-L1. High risk of developing thromboembolic events, who are unwilling to take ...
Has had prior anti-cancer monoclonal antibody (mAb), chemotherapy, targeted small molecule therapy, or radiation therapy within 4 weeks prior to the planned ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.